Protherics PLC 6 monthly Block Listing Return Individual Unapproved Options London, UK; Brentwood, TN, US: 10 April 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, today, the following 6 monthly block listing return in respect of the Company's Individual Unapproved Option arrangements has been lodged with the FSA in accordance with Listing Rule 3.5.6. Name of applicant: Protherics PLC Name of scheme: Individual Unapproved Option arrangements Period of return: From: 9 October 2006 To: 8 April 2007 Balance under scheme from previous return: 640,000 The amount by which the block scheme has been increased, Nil if the scheme has been increased since the date of the last return: Number of securities issued/allotted under scheme during Nil period: Balance under scheme not yet issued/allotted at end of 640,000 period Number and class of securities originally listed and the 810,000 Ordinary Shares (date of admission: 8 April 2005) date of admission Total number of securities in issue at the end of the period 339,169,625 | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518000 Financial Dynamics - press enquiries London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announces Blocklisting Interim Review
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- April 10, 2007 --